OPEN END TURBO PUT WARRANT - ELI LILLY & CO | Market Closed - Deutsche Boerse AG 01:38:39 2024-06-27 pm EDT | ||
| 2.89 EUR | -11.89% |
|
| Current month | -70.64% | ||
| 1 month | -71.92% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 2.89 | -11.89% |
| 24-06-26 | 3.28 | +9.33% |
| 24-06-25 | 3 | -14.04% |
| 24-06-24 | 3.49 | -24.13% |
| 24-06-21 | 4.6 | -5.15% |
Delayed Quote Deutsche Boerse AG
Last update June 27, 2024 at 01:38 pm EDT
More quotesStatic data
| Product type | Warrant Knock-Out senza Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | UBS |
| WKN | UL9LQJ |
| ISIN | DE000UL9LQJ5 |
| Date issued | 2023-11-10 |
| Strike | 934.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 29.62 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 33.85 € |
|---|---|
| Lowest since issue | 2.44 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Certificates
- Certificat
